Stem definition | Drug id | CAS RN |
---|---|---|
2797 | 128-13-2 |
Dose | Unit | Route |
---|---|---|
0.75 | g | O |
Property | Value | Reference |
---|---|---|
BDDCS (Biopharmaceutical Drug Disposition Classification System) | 2 | Benet LZ, Broccatelli F, Oprea TI |
EoM (Fraction excreted unchanged in urine) | 0.50 % | Benet LZ, Broccatelli F, Oprea TI |
MRTD (Maximum Recommended Therapeutic Daily Dose) | 38.21 µM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
Date | Agency | Company | Orphan |
---|---|---|---|
Dec. 31, 1987 | FDA | ACTAVIS LABS UT INC |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Hepatic function abnormal | 370.23 | 12.05 | 241 | 28078 | 34180 | 46623563 |
Blood bilirubin increased | 223.71 | 12.05 | 177 | 28142 | 34007 | 46623736 |
Ascites | 194.64 | 12.05 | 168 | 28151 | 36416 | 46621327 |
Hepatic encephalopathy | 182.22 | 12.05 | 99 | 28220 | 10058 | 46647685 |
Pruritus | 182.13 | 12.05 | 432 | 27887 | 241920 | 46415823 |
Hepatic failure | 170.79 | 12.05 | 150 | 28169 | 33266 | 46624477 |
Liver disorder | 156.83 | 12.05 | 150 | 28169 | 37096 | 46620647 |
Aspartate aminotransferase increased | 136.11 | 12.05 | 201 | 28118 | 78499 | 46579244 |
Platelet count decreased | 133.68 | 12.05 | 227 | 28092 | 99797 | 46557946 |
Jaundice | 119.20 | 12.05 | 115 | 28204 | 28730 | 46629013 |
Alanine aminotransferase increased | 115.87 | 12.05 | 199 | 28120 | 88252 | 46569491 |
Primary biliary cholangitis | 113.96 | 12.05 | 38 | 28281 | 1133 | 46656610 |
Hepatocellular carcinoma | 113.49 | 12.05 | 48 | 28271 | 2791 | 46654952 |
Graft versus host disease | 109.31 | 12.05 | 61 | 28258 | 6527 | 46651216 |
Venoocclusive liver disease | 106.83 | 12.05 | 52 | 28267 | 4199 | 46653544 |
Cholangitis | 99.25 | 12.05 | 51 | 28268 | 4623 | 46653120 |
Infective pulmonary exacerbation of cystic fibrosis | 97.69 | 12.05 | 68 | 28251 | 10739 | 46647004 |
Hepatic cirrhosis | 95.50 | 12.05 | 78 | 28241 | 15654 | 46642089 |
Rheumatoid arthritis | 92.48 | 12.05 | 17 | 28302 | 240198 | 46417545 |
Drug ineffective | 86.82 | 12.05 | 176 | 28143 | 677662 | 45980081 |
Cytomegalovirus infection | 85.83 | 12.05 | 78 | 28241 | 18066 | 46639677 |
Disseminated intravascular coagulation | 82.74 | 12.05 | 78 | 28241 | 18927 | 46638816 |
Blood alkaline phosphatase increased | 81.50 | 12.05 | 110 | 28209 | 39499 | 46618244 |
Drug hypersensitivity | 75.24 | 12.05 | 27 | 28292 | 243798 | 46413945 |
Pain | 73.51 | 12.05 | 110 | 28209 | 476838 | 46180905 |
Cholestasis | 73.37 | 12.05 | 86 | 28233 | 26807 | 46630936 |
Completed suicide | 72.25 | 12.05 | 4 | 28315 | 145916 | 46511827 |
Hepatic cancer | 69.27 | 12.05 | 35 | 28284 | 3062 | 46654681 |
Thrombotic microangiopathy | 67.54 | 12.05 | 49 | 28270 | 8257 | 46649486 |
Febrile neutropenia | 66.83 | 12.05 | 165 | 28154 | 94462 | 46563281 |
Hyperbilirubinaemia | 65.98 | 12.05 | 53 | 28266 | 10385 | 46647358 |
Interstitial lung disease | 64.91 | 12.05 | 117 | 28202 | 53832 | 46603911 |
Renal impairment | 62.69 | 12.05 | 139 | 28180 | 74233 | 46583510 |
Pyrexia | 62.52 | 12.05 | 393 | 27926 | 348409 | 46309334 |
Cholestasis of pregnancy | 62.16 | 12.05 | 24 | 28295 | 1100 | 46656643 |
Oesophageal varices haemorrhage | 60.19 | 12.05 | 24 | 28295 | 1199 | 46656544 |
Acute graft versus host disease in skin | 58.90 | 12.05 | 31 | 28288 | 2951 | 46654792 |
Neutrophil count decreased | 58.51 | 12.05 | 99 | 28220 | 43327 | 46614416 |
Acute graft versus host disease | 55.35 | 12.05 | 33 | 28286 | 3997 | 46653746 |
Autoimmune hepatitis | 54.39 | 12.05 | 42 | 28277 | 7772 | 46649971 |
Cholangitis sclerosing | 53.74 | 12.05 | 21 | 28298 | 994 | 46656749 |
Total bile acids increased | 52.40 | 12.05 | 13 | 28306 | 128 | 46657615 |
Decreased appetite | 51.27 | 12.05 | 243 | 28076 | 193593 | 46464150 |
Gamma-glutamyltransferase increased | 50.44 | 12.05 | 78 | 28241 | 31662 | 46626081 |
Cytomegalovirus viraemia | 49.66 | 12.05 | 32 | 28287 | 4446 | 46653297 |
Liver transplant rejection | 47.47 | 12.05 | 21 | 28298 | 1362 | 46656381 |
Varices oesophageal | 46.48 | 12.05 | 26 | 28293 | 2793 | 46654950 |
Venoocclusive disease | 46.38 | 12.05 | 23 | 28296 | 1933 | 46655810 |
Stomatitis | 46.00 | 12.05 | 117 | 28202 | 68180 | 46589563 |
Chronic graft versus host disease | 44.57 | 12.05 | 25 | 28294 | 2700 | 46655043 |
Drug-induced liver injury | 42.65 | 12.05 | 64 | 28255 | 25304 | 46632439 |
Drug intolerance | 42.48 | 12.05 | 18 | 28301 | 147031 | 46510712 |
Joint swelling | 42.41 | 12.05 | 24 | 28295 | 166049 | 46491694 |
Portal hypertension | 41.39 | 12.05 | 26 | 28293 | 3457 | 46654286 |
Cytomegalovirus test positive | 41.11 | 12.05 | 24 | 28295 | 2796 | 46654947 |
Anaemia | 40.74 | 12.05 | 280 | 28039 | 255499 | 46402244 |
Pulmonary malformation | 40.63 | 12.05 | 10 | 28309 | 95 | 46657648 |
Liver transplant | 39.06 | 12.05 | 22 | 28297 | 2395 | 46655348 |
Hypoproteinaemia | 38.81 | 12.05 | 20 | 28299 | 1823 | 46655920 |
Cystitis haemorrhagic | 38.48 | 12.05 | 25 | 28294 | 3522 | 46654221 |
Contraindicated product administered | 37.18 | 12.05 | 3 | 28316 | 79944 | 46577799 |
Pain in extremity | 35.67 | 12.05 | 64 | 28255 | 258616 | 46399127 |
Adenoviral hepatitis | 35.65 | 12.05 | 11 | 28308 | 254 | 46657489 |
Pancytopenia | 35.54 | 12.05 | 123 | 28196 | 84935 | 46572808 |
Cystic fibrosis | 35.20 | 12.05 | 24 | 28295 | 3664 | 46654079 |
White blood cell count decreased | 34.35 | 12.05 | 147 | 28172 | 112084 | 46545659 |
Bile duct stone | 34.13 | 12.05 | 23 | 28296 | 3444 | 46654299 |
Hepatomegaly | 34.08 | 12.05 | 38 | 28281 | 11215 | 46646528 |
Sepsis | 33.39 | 12.05 | 167 | 28152 | 135847 | 46521896 |
Respiratory tract malformation | 32.99 | 12.05 | 8 | 28311 | 71 | 46657672 |
Injection site pain | 32.77 | 12.05 | 12 | 28307 | 107140 | 46550603 |
Hypoalbuminaemia | 32.06 | 12.05 | 35 | 28284 | 10092 | 46647651 |
Blood lactate dehydrogenase increased | 32.04 | 12.05 | 50 | 28269 | 20450 | 46637293 |
Splenomegaly | 31.57 | 12.05 | 34 | 28285 | 9654 | 46648089 |
Treatment failure | 30.98 | 12.05 | 9 | 28310 | 93078 | 46564665 |
Therapy interrupted | 30.24 | 12.05 | 35 | 28284 | 10756 | 46646987 |
Lung cyst | 29.87 | 12.05 | 8 | 28311 | 109 | 46657634 |
Tonsillar haemorrhage | 29.84 | 12.05 | 9 | 28310 | 192 | 46657551 |
Cardiac failure | 29.48 | 12.05 | 111 | 28208 | 79837 | 46577906 |
Palmar-plantar erythrodysaesthesia syndrome | 29.38 | 12.05 | 48 | 28271 | 20403 | 46637340 |
Hypersensitivity | 29.03 | 12.05 | 29 | 28290 | 150292 | 46507451 |
Coagulation test abnormal | 28.91 | 12.05 | 12 | 28307 | 665 | 46657078 |
Aplastic anaemia | 28.56 | 12.05 | 28 | 28291 | 7125 | 46650618 |
Multiple organ dysfunction syndrome | 28.21 | 12.05 | 82 | 28237 | 51628 | 46606115 |
Blood alkaline phosphatase abnormal | 28.12 | 12.05 | 10 | 28309 | 363 | 46657380 |
Therapeutic product effect decreased | 27.46 | 12.05 | 8 | 28311 | 82593 | 46575150 |
Staphylococcal sepsis | 27.34 | 12.05 | 28 | 28291 | 7504 | 46650239 |
Pneumonia cytomegaloviral | 26.79 | 12.05 | 16 | 28303 | 1944 | 46655799 |
Enterococcal sepsis | 26.66 | 12.05 | 14 | 28305 | 1326 | 46656417 |
Bacterial sepsis | 26.65 | 12.05 | 20 | 28299 | 3547 | 46654196 |
Hepatitis cholestatic | 26.40 | 12.05 | 26 | 28293 | 6651 | 46651092 |
Hepatic necrosis | 26.33 | 12.05 | 24 | 28295 | 5577 | 46652166 |
Intentional overdose | 26.27 | 12.05 | 4 | 28315 | 64940 | 46592803 |
Acute graft versus host disease in intestine | 26.24 | 12.05 | 15 | 28304 | 1680 | 46656063 |
Venous haemorrhage | 26.04 | 12.05 | 8 | 28311 | 182 | 46657561 |
Hyperuricaemia | 25.74 | 12.05 | 22 | 28297 | 4695 | 46653048 |
Pleural effusion | 25.64 | 12.05 | 109 | 28210 | 82843 | 46574900 |
Vanishing bile duct syndrome | 25.63 | 12.05 | 11 | 28308 | 663 | 46657080 |
Hepatitis fulminant | 25.25 | 12.05 | 19 | 28300 | 3383 | 46654360 |
Hepatic fibrosis | 25.10 | 12.05 | 18 | 28301 | 2977 | 46654766 |
Candida test positive | 25.10 | 12.05 | 12 | 28307 | 931 | 46656812 |
Ammonia increased | 25.09 | 12.05 | 21 | 28298 | 4356 | 46653387 |
Arthralgia | 25.00 | 12.05 | 125 | 28194 | 364478 | 46293265 |
Haemophagocytic lymphohistiocytosis | 24.97 | 12.05 | 28 | 28291 | 8314 | 46649429 |
Haemorrhage subcutaneous | 23.30 | 12.05 | 17 | 28302 | 2889 | 46654854 |
Coma hepatic | 23.25 | 12.05 | 10 | 28309 | 606 | 46657137 |
Engraftment syndrome | 22.85 | 12.05 | 8 | 28311 | 277 | 46657466 |
Muscle spasms | 22.36 | 12.05 | 25 | 28294 | 123088 | 46534655 |
Abdominal discomfort | 22.09 | 12.05 | 36 | 28283 | 151129 | 46506614 |
Hepatitis C | 22.06 | 12.05 | 23 | 28296 | 6295 | 46651448 |
Hyperammonaemia | 21.76 | 12.05 | 20 | 28299 | 4696 | 46653047 |
Alopecia | 21.63 | 12.05 | 41 | 28278 | 162373 | 46495370 |
Premature baby | 21.41 | 12.05 | 39 | 28280 | 18073 | 46639670 |
Histoplasmosis | 21.05 | 12.05 | 13 | 28306 | 1677 | 46656066 |
Cardiac tamponade | 20.77 | 12.05 | 19 | 28300 | 4435 | 46653308 |
Enterocolitis | 20.72 | 12.05 | 22 | 28297 | 6146 | 46651597 |
Chest pain | 20.56 | 12.05 | 48 | 28271 | 176276 | 46481467 |
Overdose | 20.46 | 12.05 | 19 | 28300 | 101960 | 46555783 |
Therapy cessation | 20.45 | 12.05 | 48 | 28271 | 26581 | 46631162 |
Aspergillus infection | 20.41 | 12.05 | 23 | 28296 | 6867 | 46650876 |
Injection site erythema | 20.10 | 12.05 | 10 | 28309 | 74417 | 46583326 |
Spider naevus | 20.07 | 12.05 | 6 | 28313 | 124 | 46657619 |
Loss of personal independence in daily activities | 20.02 | 12.05 | 5 | 28314 | 57178 | 46600565 |
Maternal exposure during breast feeding | 19.43 | 12.05 | 15 | 28304 | 2774 | 46654969 |
Adenovirus infection | 19.24 | 12.05 | 15 | 28304 | 2815 | 46654928 |
Blood creatine phosphokinase increased | 19.18 | 12.05 | 48 | 28271 | 27676 | 46630067 |
Cholangitis acute | 19.13 | 12.05 | 8 | 28311 | 452 | 46657291 |
Altered state of consciousness | 18.93 | 12.05 | 43 | 28276 | 23305 | 46634438 |
Osteoarthritis | 18.87 | 12.05 | 7 | 28312 | 62018 | 46595725 |
Cytokine release syndrome | 18.82 | 12.05 | 21 | 28298 | 6202 | 46651541 |
Swelling | 18.81 | 12.05 | 29 | 28290 | 124482 | 46533261 |
Faeces soft | 18.65 | 12.05 | 16 | 28303 | 3432 | 46654311 |
Arthritis | 18.56 | 12.05 | 12 | 28307 | 77304 | 46580439 |
Chronic obstructive pulmonary disease | 18.40 | 12.05 | 6 | 28313 | 57627 | 46600116 |
Premature labour | 18.27 | 12.05 | 28 | 28291 | 11271 | 46646472 |
Fatigue | 18.25 | 12.05 | 260 | 28059 | 608437 | 46049306 |
Blood albumin abnormal | 18.10 | 12.05 | 7 | 28312 | 322 | 46657421 |
Acute myeloid leukaemia recurrent | 18.06 | 12.05 | 11 | 28308 | 1385 | 46656358 |
Sinusitis | 17.95 | 12.05 | 32 | 28287 | 129736 | 46528007 |
Enterocolitis bacterial | 17.56 | 12.05 | 6 | 28313 | 193 | 46657550 |
Amylase increased | 17.51 | 12.05 | 19 | 28300 | 5440 | 46652303 |
Hyperamylasaemia | 17.31 | 12.05 | 7 | 28312 | 363 | 46657380 |
Asthma | 17.28 | 12.05 | 18 | 28301 | 91524 | 46566219 |
Toxicity to various agents | 17.27 | 12.05 | 68 | 28251 | 211698 | 46446045 |
Mucosal disorder | 17.25 | 12.05 | 12 | 28307 | 1892 | 46655851 |
Foetor hepaticus | 17.15 | 12.05 | 3 | 28316 | 3 | 46657740 |
Cholecystitis acute | 17.14 | 12.05 | 22 | 28297 | 7516 | 46650227 |
Injection site reaction | 17.11 | 12.05 | 4 | 28315 | 47845 | 46609898 |
Fixed eruption | 17.11 | 12.05 | 9 | 28310 | 856 | 46656887 |
Spinal compression fracture | 16.82 | 12.05 | 29 | 28290 | 12874 | 46644869 |
Hallucination, tactile | 16.68 | 12.05 | 6 | 28313 | 225 | 46657518 |
Migraine | 16.63 | 12.05 | 11 | 28308 | 70015 | 46587728 |
Acute graft versus host disease in liver | 16.59 | 12.05 | 8 | 28311 | 632 | 46657111 |
Gait disturbance | 16.57 | 12.05 | 40 | 28279 | 145223 | 46512520 |
Anxiety | 16.43 | 12.05 | 56 | 28263 | 181901 | 46475842 |
Transfusion | 16.29 | 12.05 | 29 | 28290 | 13202 | 46644541 |
Liver carcinoma ruptured | 16.29 | 12.05 | 3 | 28316 | 5 | 46657738 |
Acute lymphocytic leukaemia recurrent | 16.22 | 12.05 | 12 | 28307 | 2083 | 46655660 |
Ocular icterus | 15.95 | 12.05 | 15 | 28304 | 3625 | 46654118 |
Anion gap normal | 15.93 | 12.05 | 3 | 28316 | 6 | 46657737 |
Cerebrovascular accident | 15.77 | 12.05 | 23 | 28296 | 101016 | 46556727 |
Hepatitis B | 15.77 | 12.05 | 15 | 28304 | 3678 | 46654065 |
Depression | 15.60 | 12.05 | 52 | 28267 | 170052 | 46487691 |
Cholelithiasis | 15.34 | 12.05 | 55 | 28264 | 38626 | 46619117 |
Gastrointestinal mucosal disorder | 15.32 | 12.05 | 8 | 28311 | 749 | 46656994 |
Injection site swelling | 15.17 | 12.05 | 3 | 28316 | 40324 | 46617419 |
Myocarditis | 15.16 | 12.05 | 21 | 28298 | 7718 | 46650025 |
Epstein-Barr virus associated lymphoproliferative disorder | 15.01 | 12.05 | 10 | 28309 | 1469 | 46656274 |
Intraventricular haemorrhage neonatal | 14.90 | 12.05 | 5 | 28314 | 152 | 46657591 |
Septic shock | 14.84 | 12.05 | 72 | 28247 | 57821 | 46599922 |
Drug eruption | 14.83 | 12.05 | 37 | 28282 | 21292 | 46636451 |
Oedema | 14.81 | 12.05 | 80 | 28239 | 66991 | 46590752 |
Cholangitis infective | 14.78 | 12.05 | 5 | 28314 | 156 | 46657587 |
Pregnancy | 14.76 | 12.05 | 43 | 28276 | 27094 | 46630649 |
Liver injury | 14.71 | 12.05 | 31 | 28288 | 15970 | 46641773 |
Hepatitis | 14.69 | 12.05 | 48 | 28271 | 32167 | 46625576 |
Renal tubular disorder | 14.49 | 12.05 | 12 | 28307 | 2453 | 46655290 |
Sopor | 14.42 | 12.05 | 35 | 28284 | 19793 | 46637950 |
Pelvic venous thrombosis | 14.31 | 12.05 | 10 | 28309 | 1587 | 46656156 |
Bronchopulmonary aspergillosis | 14.18 | 12.05 | 20 | 28299 | 7476 | 46650267 |
Transposition of the great vessels | 14.18 | 12.05 | 5 | 28314 | 177 | 46657566 |
Graft versus host disease in gastrointestinal tract | 14.13 | 12.05 | 12 | 28307 | 2538 | 46655205 |
Dyspnoea | 14.12 | 12.05 | 224 | 28095 | 515324 | 46142419 |
Viral haemorrhagic cystitis | 13.92 | 12.05 | 7 | 28312 | 606 | 46657137 |
Hyponatraemia | 13.82 | 12.05 | 107 | 28212 | 101225 | 46556518 |
Transplantation complication | 13.80 | 12.05 | 4 | 28315 | 74 | 46657669 |
Musculoskeletal stiffness | 13.70 | 12.05 | 24 | 28295 | 97969 | 46559774 |
Wrong technique in product usage process | 13.68 | 12.05 | 8 | 28311 | 54414 | 46603329 |
Hepatic artery stenosis | 13.54 | 12.05 | 3 | 28316 | 17 | 46657726 |
Biliary cirrhosis | 13.50 | 12.05 | 4 | 28315 | 80 | 46657663 |
Immunosuppressant drug level increased | 13.39 | 12.05 | 13 | 28306 | 3269 | 46654474 |
Myositis | 13.36 | 12.05 | 20 | 28299 | 7884 | 46649859 |
Hepatic mass | 13.32 | 12.05 | 9 | 28310 | 1353 | 46656390 |
Urine uric acid increased | 13.26 | 12.05 | 3 | 28316 | 19 | 46657724 |
Septic arthritis staphylococcal | 13.25 | 12.05 | 6 | 28313 | 411 | 46657332 |
Portal hypertensive gastropathy | 13.24 | 12.05 | 7 | 28312 | 672 | 46657071 |
Systemic lupus erythematosus | 13.24 | 12.05 | 12 | 28307 | 65168 | 46592575 |
Upper respiratory tract inflammation | 13.18 | 12.05 | 12 | 28307 | 2783 | 46654960 |
Hypokalaemia | 13.16 | 12.05 | 95 | 28224 | 87929 | 46569814 |
Haematuria | 13.14 | 12.05 | 41 | 28278 | 26817 | 46630926 |
Renal glycosuria | 13.13 | 12.05 | 3 | 28316 | 20 | 46657723 |
Off label use | 13.11 | 12.05 | 312 | 28007 | 379529 | 46278214 |
Biliary tract disorder | 13.08 | 12.05 | 7 | 28312 | 689 | 46657054 |
Dizziness | 12.96 | 12.05 | 138 | 28181 | 340276 | 46317467 |
Serum ferritin increased | 12.94 | 12.05 | 16 | 28303 | 5267 | 46652476 |
Erythema multiforme | 12.90 | 12.05 | 22 | 28297 | 9682 | 46648061 |
Graft versus host disease in skin | 12.84 | 12.05 | 11 | 28308 | 2356 | 46655387 |
Caesarean section | 12.82 | 12.05 | 30 | 28289 | 16573 | 46641170 |
Epstein-Barr virus infection | 12.68 | 12.05 | 18 | 28301 | 6766 | 46650977 |
VIIIth nerve lesion | 12.65 | 12.05 | 3 | 28316 | 24 | 46657719 |
Myocardial infarction | 12.65 | 12.05 | 25 | 28294 | 97503 | 46560240 |
Mucosal inflammation | 12.64 | 12.05 | 52 | 28267 | 38924 | 46618819 |
Lower respiratory tract infection | 12.62 | 12.05 | 9 | 28310 | 55080 | 46602663 |
Bile duct stenosis | 12.53 | 12.05 | 8 | 28311 | 1093 | 46656650 |
Pneumonia fungal | 12.51 | 12.05 | 14 | 28305 | 4146 | 46653597 |
Neutropenia | 12.33 | 12.05 | 137 | 28182 | 143067 | 46514676 |
Feeling abnormal | 12.32 | 12.05 | 37 | 28282 | 125023 | 46532720 |
Psoriasis | 12.16 | 12.05 | 18 | 28301 | 78586 | 46579157 |
Corynebacterium sepsis | 12.14 | 12.05 | 3 | 28316 | 29 | 46657714 |
Right atrial dilatation | 12.09 | 12.05 | 6 | 28313 | 505 | 46657238 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Hepatic function abnormal | 407.81 | 11.62 | 323 | 26806 | 41622 | 29883727 |
Hepatic encephalopathy | 219.52 | 11.62 | 145 | 26984 | 14047 | 29911302 |
Hepatic cancer | 185.77 | 11.62 | 99 | 27030 | 6449 | 29918900 |
Blood bilirubin increased | 168.23 | 11.62 | 186 | 26943 | 36450 | 29888899 |
Hepatic failure | 165.30 | 11.62 | 178 | 26951 | 33865 | 29891484 |
Liver disorder | 154.21 | 11.62 | 161 | 26968 | 29561 | 29895788 |
Ascites | 148.98 | 11.62 | 173 | 26956 | 35748 | 29889601 |
Infective pulmonary exacerbation of cystic fibrosis | 145.83 | 11.62 | 93 | 27036 | 8479 | 29916870 |
Cholangitis | 136.09 | 11.62 | 86 | 27043 | 7716 | 29917633 |
Venoocclusive liver disease | 136.05 | 11.62 | 81 | 27048 | 6532 | 29918817 |
Palmar-plantar erythrodysaesthesia syndrome | 118.13 | 11.62 | 102 | 27027 | 14768 | 29910581 |
Pyrexia | 105.45 | 11.62 | 535 | 26594 | 293954 | 29631395 |
Hepatocellular carcinoma | 95.31 | 11.62 | 75 | 27054 | 9535 | 29915814 |
Graft versus host disease | 89.61 | 11.62 | 74 | 27055 | 10076 | 29915273 |
Platelet count decreased | 89.40 | 11.62 | 254 | 26875 | 105875 | 29819474 |
Aspartate aminotransferase increased | 82.17 | 11.62 | 179 | 26950 | 63243 | 29862106 |
Interstitial lung disease | 80.39 | 11.62 | 172 | 26957 | 60025 | 29865324 |
Graft versus host disease in skin | 74.58 | 11.62 | 43 | 27086 | 3264 | 29922085 |
Acute graft versus host disease in skin | 74.33 | 11.62 | 48 | 27081 | 4468 | 29920881 |
Jaundice | 74.07 | 11.62 | 117 | 27012 | 32369 | 29892980 |
Completed suicide | 70.79 | 11.62 | 5 | 27124 | 99487 | 29825862 |
Acute graft versus host disease | 69.71 | 11.62 | 51 | 27078 | 5813 | 29919536 |
Renal impairment | 64.62 | 11.62 | 195 | 26934 | 83989 | 29841360 |
Cholangitis sclerosing | 64.30 | 11.62 | 26 | 27103 | 894 | 29924455 |
Death | 61.19 | 11.62 | 147 | 26982 | 357136 | 29568213 |
Cystitis haemorrhagic | 60.02 | 11.62 | 43 | 27086 | 4744 | 29920605 |
Alanine aminotransferase increased | 58.83 | 11.62 | 174 | 26955 | 74102 | 29851247 |
Disseminated intravascular coagulation | 57.80 | 11.62 | 85 | 27044 | 22086 | 29903263 |
Cytomegalovirus infection | 57.78 | 11.62 | 88 | 27041 | 23586 | 29901763 |
Toxicity to various agents | 57.25 | 11.62 | 46 | 27083 | 177137 | 29748212 |
Chronic graft versus host disease | 56.29 | 11.62 | 39 | 27090 | 4080 | 29921269 |
Myocardial infarction | 55.79 | 11.62 | 22 | 27107 | 125603 | 29799746 |
Decreased appetite | 55.22 | 11.62 | 275 | 26854 | 149635 | 29775714 |
Cytomegalovirus viraemia | 53.15 | 11.62 | 43 | 27086 | 5686 | 29919663 |
Thrombotic microangiopathy | 52.61 | 11.62 | 51 | 27078 | 8559 | 29916790 |
Dyspnoea | 51.75 | 11.62 | 144 | 26985 | 333151 | 29592198 |
Gamma-glutamyltransferase increased | 50.13 | 11.62 | 93 | 27036 | 29257 | 29896092 |
Oesophageal varices haemorrhage | 49.16 | 11.62 | 32 | 27097 | 3019 | 29922330 |
Venoocclusive disease | 48.82 | 11.62 | 30 | 27099 | 2560 | 29922789 |
Drug abuse | 48.58 | 11.62 | 8 | 27121 | 82064 | 29843285 |
Febrile neutropenia | 48.32 | 11.62 | 208 | 26921 | 106485 | 29818864 |
Acute graft versus host disease in liver | 47.33 | 11.62 | 23 | 27106 | 1231 | 29924118 |
Drug-induced liver injury | 46.25 | 11.62 | 75 | 27054 | 21199 | 29904150 |
Fatigue | 45.81 | 11.62 | 144 | 26985 | 320529 | 29604820 |
Drug ineffective | 45.78 | 11.62 | 157 | 26972 | 340230 | 29585119 |
Bile duct stone | 44.15 | 11.62 | 27 | 27102 | 2284 | 29923065 |
Blood alkaline phosphatase increased | 43.18 | 11.62 | 91 | 27038 | 31396 | 29893953 |
Engraftment syndrome | 43.06 | 11.62 | 19 | 27110 | 814 | 29924535 |
White blood cell count decreased | 42.98 | 11.62 | 170 | 26959 | 83777 | 29841572 |
Liver transplant rejection | 42.81 | 11.62 | 26 | 27103 | 2172 | 29923177 |
Cholangitis acute | 42.05 | 11.62 | 18 | 27111 | 716 | 29924633 |
Acute graft versus host disease in intestine | 40.66 | 11.62 | 26 | 27103 | 2379 | 29922970 |
Hepatitis C | 39.39 | 11.62 | 54 | 27075 | 13151 | 29912198 |
Hepatic cirrhosis | 38.37 | 11.62 | 59 | 27070 | 15940 | 29909409 |
Hyperbilirubinaemia | 35.84 | 11.62 | 59 | 27070 | 16883 | 29908466 |
Neutrophil count decreased | 35.06 | 11.62 | 101 | 27028 | 42353 | 29882996 |
Dizziness | 34.19 | 11.62 | 79 | 27050 | 194830 | 29730519 |
Cerebral infarction | 33.61 | 11.62 | 74 | 27055 | 26299 | 29899050 |
Glomerulosclerosis | 33.47 | 11.62 | 15 | 27114 | 667 | 29924682 |
Product dose omission issue | 33.21 | 11.62 | 21 | 27108 | 91610 | 29833739 |
Amylase increased | 30.90 | 11.62 | 32 | 27097 | 5809 | 29919540 |
Stomatitis | 30.12 | 11.62 | 88 | 27041 | 37191 | 29888158 |
Liver carcinoma ruptured | 29.62 | 11.62 | 9 | 27120 | 129 | 29925220 |
Pain | 29.45 | 11.62 | 71 | 27058 | 172570 | 29752779 |
Hyperammonaemia | 28.77 | 11.62 | 30 | 27099 | 5490 | 29919859 |
Anaemia | 28.68 | 11.62 | 301 | 26828 | 207691 | 29717658 |
Cholelithiasis | 28.36 | 11.62 | 59 | 27070 | 20166 | 29905183 |
Cerebrovascular accident | 27.76 | 11.62 | 21 | 27108 | 83456 | 29841893 |
Blood lactate dehydrogenase increased | 27.61 | 11.62 | 59 | 27070 | 20542 | 29904807 |
Intentional overdose | 27.01 | 11.62 | 3 | 27126 | 41478 | 29883871 |
Eosinophilic colitis | 26.88 | 11.62 | 9 | 27120 | 179 | 29925170 |
Hyperhidrosis | 26.26 | 11.62 | 14 | 27115 | 67076 | 29858273 |
Altered state of consciousness | 25.50 | 11.62 | 56 | 27073 | 19863 | 29905486 |
Hypoalbuminaemia | 25.33 | 11.62 | 40 | 27089 | 11052 | 29914297 |
Cystic fibrosis related diabetes | 25.28 | 11.62 | 8 | 27121 | 132 | 29925217 |
Graft versus host disease in liver | 25.22 | 11.62 | 14 | 27115 | 988 | 29924361 |
Liver abscess | 25.13 | 11.62 | 22 | 27107 | 3240 | 29922109 |
Anxiety | 24.66 | 11.62 | 27 | 27102 | 89844 | 29835505 |
Overdose | 24.65 | 11.62 | 24 | 27105 | 84313 | 29841036 |
Graft versus host disease in gastrointestinal tract | 24.25 | 11.62 | 21 | 27108 | 3048 | 29922301 |
Liver transplant | 23.83 | 11.62 | 20 | 27109 | 2782 | 29922567 |
Hepatorenal syndrome | 23.61 | 11.62 | 19 | 27110 | 2492 | 29922857 |
Cardiac failure congestive | 23.56 | 11.62 | 25 | 27104 | 84382 | 29840967 |
Coronary artery disease | 23.23 | 11.62 | 8 | 27121 | 49704 | 29875645 |
Hyperuricaemia | 23.21 | 11.62 | 31 | 27098 | 7363 | 29917986 |
Human herpesvirus 6 infection | 23.20 | 11.62 | 17 | 27112 | 1941 | 29923408 |
Cytomegalovirus test positive | 23.04 | 11.62 | 22 | 27107 | 3623 | 29921726 |
Fall | 22.95 | 11.62 | 86 | 27043 | 181786 | 29743563 |
Joint swelling | 22.92 | 11.62 | 7 | 27122 | 46939 | 29878410 |
Bile duct stenosis | 22.54 | 11.62 | 14 | 27115 | 1217 | 29924132 |
Pleural effusion | 22.50 | 11.62 | 129 | 27000 | 73937 | 29851412 |
Hemivertebra | 22.50 | 11.62 | 7 | 27122 | 109 | 29925240 |
Enterocolitis | 22.48 | 11.62 | 29 | 27100 | 6658 | 29918691 |
Discharge | 22.15 | 11.62 | 7 | 27122 | 115 | 29925234 |
Stem cell transplant | 21.92 | 11.62 | 17 | 27112 | 2114 | 29923235 |
Syncope | 21.69 | 11.62 | 27 | 27102 | 84876 | 29840473 |
Viral haemorrhagic cystitis | 21.59 | 11.62 | 12 | 27117 | 849 | 29924500 |
Aplasia | 21.14 | 11.62 | 22 | 27107 | 4015 | 29921334 |
Drug eruption | 21.01 | 11.62 | 48 | 27081 | 17478 | 29907871 |
Cystic fibrosis | 20.95 | 11.62 | 17 | 27112 | 2257 | 29923092 |
Kidney fibrosis | 20.08 | 11.62 | 16 | 27113 | 2069 | 29923280 |
Blood urea increased | 19.77 | 11.62 | 68 | 27061 | 31313 | 29894036 |
Pulmonary alveolar haemorrhage | 19.76 | 11.62 | 27 | 27102 | 6554 | 29918795 |
Peripheral swelling | 19.50 | 11.62 | 16 | 27113 | 61058 | 29864291 |
Mucosal disorder | 19.47 | 11.62 | 14 | 27115 | 1553 | 29923796 |
Autoimmune hepatitis | 19.42 | 11.62 | 20 | 27109 | 3607 | 29921742 |
Haemobilia | 19.41 | 11.62 | 8 | 27121 | 289 | 29925060 |
Hypoaldosteronism | 19.30 | 11.62 | 7 | 27122 | 178 | 29925171 |
Pain in extremity | 19.03 | 11.62 | 45 | 27084 | 110176 | 29815173 |
Pouchitis | 18.81 | 11.62 | 10 | 27119 | 647 | 29924702 |
Hypotension | 18.66 | 11.62 | 106 | 27023 | 200459 | 29724890 |
Rheumatoid arthritis | 18.62 | 11.62 | 7 | 27122 | 41190 | 29884159 |
Adenovirus infection | 18.41 | 11.62 | 21 | 27108 | 4247 | 29921102 |
Prothrombin level decreased | 18.07 | 11.62 | 12 | 27117 | 1170 | 29924179 |
Proctitis haemorrhagic | 18.02 | 11.62 | 3 | 27126 | 0 | 29925349 |
Blood albumin decreased | 17.96 | 11.62 | 37 | 27092 | 12555 | 29912794 |
Psoriasis | 17.95 | 11.62 | 8 | 27121 | 42498 | 29882851 |
Hepatic cancer recurrent | 17.80 | 11.62 | 8 | 27121 | 358 | 29924991 |
Hyperplasia | 17.69 | 11.62 | 9 | 27120 | 532 | 29924817 |
Cardiac disorder | 17.66 | 11.62 | 7 | 27122 | 39886 | 29885463 |
Dilatation intrahepatic duct acquired | 17.58 | 11.62 | 5 | 27124 | 56 | 29925293 |
Chronic obstructive pulmonary disease | 17.50 | 11.62 | 10 | 27119 | 46116 | 29879233 |
Intentional product misuse | 17.23 | 11.62 | 5 | 27124 | 34662 | 29890687 |
Erythema multiforme | 17.14 | 11.62 | 28 | 27101 | 7957 | 29917392 |
C-reactive protein increased | 16.83 | 11.62 | 81 | 27048 | 43392 | 29881957 |
Capillary leak syndrome | 16.47 | 11.62 | 13 | 27116 | 1659 | 29923690 |
Varices oesophageal | 16.40 | 11.62 | 18 | 27111 | 3491 | 29921858 |
Multiple organ dysfunction syndrome | 16.38 | 11.62 | 106 | 27023 | 63381 | 29861968 |
Bronchopulmonary aspergillosis | 16.25 | 11.62 | 35 | 27094 | 12249 | 29913100 |
Epstein-Barr virus associated lymphoproliferative disorder | 16.09 | 11.62 | 13 | 27116 | 1715 | 29923634 |
Asthenia | 16.05 | 11.62 | 126 | 27003 | 221164 | 29704185 |
Biliary tract infection | 16.01 | 11.62 | 8 | 27121 | 455 | 29924894 |
Arthralgia | 15.97 | 11.62 | 66 | 27063 | 135725 | 29789624 |
Cystitis viral | 15.94 | 11.62 | 8 | 27121 | 459 | 29924890 |
Cholecystitis | 15.90 | 11.62 | 30 | 27099 | 9549 | 29915800 |
Chest pain | 15.90 | 11.62 | 54 | 27075 | 117573 | 29807776 |
Portal vein occlusion | 15.89 | 11.62 | 5 | 27124 | 81 | 29925268 |
Oesophageal atresia | 15.83 | 11.62 | 8 | 27121 | 466 | 29924883 |
Drug interaction | 15.72 | 11.62 | 111 | 27018 | 199457 | 29725892 |
Memory impairment | 15.69 | 11.62 | 7 | 27122 | 37167 | 29888182 |
Porphyria non-acute | 15.58 | 11.62 | 8 | 27121 | 482 | 29924867 |
Faecalith | 15.49 | 11.62 | 3 | 27126 | 4 | 29925345 |
Epstein-Barr virus infection | 15.06 | 11.62 | 24 | 27105 | 6682 | 29918667 |
Portal vein thrombosis | 14.87 | 11.62 | 17 | 27112 | 3447 | 29921902 |
Acute lymphocytic leukaemia recurrent | 14.81 | 11.62 | 15 | 27114 | 2652 | 29922697 |
Feeling abnormal | 14.54 | 11.62 | 18 | 27111 | 56738 | 29868611 |
Bacterial infection | 14.52 | 11.62 | 34 | 27095 | 12576 | 29912773 |
Escherichia sepsis | 14.50 | 11.62 | 18 | 27111 | 3976 | 29921373 |
Macroglossia | 14.40 | 11.62 | 6 | 27123 | 223 | 29925126 |
Drug hypersensitivity | 14.36 | 11.62 | 25 | 27104 | 68494 | 29856855 |
Pulmonary embolism | 14.21 | 11.62 | 31 | 27098 | 78104 | 29847245 |
Antimitochondrial antibody positive | 14.05 | 11.62 | 4 | 27125 | 45 | 29925304 |
Pancreatic enzymes increased | 13.97 | 11.62 | 8 | 27121 | 599 | 29924750 |
Polychromasia | 13.71 | 11.62 | 5 | 27124 | 129 | 29925220 |
Hepatic vein occlusion | 13.68 | 11.62 | 5 | 27124 | 130 | 29925219 |
Staphylococcal sepsis | 13.67 | 11.62 | 28 | 27101 | 9463 | 29915886 |
Tumour embolism | 13.38 | 11.62 | 4 | 27125 | 54 | 29925295 |
Acute myocardial infarction | 13.34 | 11.62 | 17 | 27112 | 52922 | 29872427 |
Vision blurred | 13.29 | 11.62 | 11 | 27118 | 41805 | 29883544 |
Depression | 13.27 | 11.62 | 40 | 27089 | 90397 | 29834952 |
Engraft failure | 13.27 | 11.62 | 7 | 27122 | 446 | 29924903 |
Vanishing bile duct syndrome | 13.26 | 11.62 | 8 | 27121 | 660 | 29924689 |
Cholestasis | 13.13 | 11.62 | 51 | 27078 | 24899 | 29900450 |
Neonatal respiratory distress | 13.05 | 11.62 | 7 | 27122 | 461 | 29924888 |
Cytomegalovirus duodenitis | 12.93 | 11.62 | 4 | 27125 | 61 | 29925288 |
Bone marrow transplant | 12.84 | 11.62 | 9 | 27120 | 959 | 29924390 |
Cytokine release syndrome | 12.79 | 11.62 | 28 | 27101 | 9905 | 29915444 |
Haemophilic arthropathy | 12.76 | 11.62 | 5 | 27124 | 158 | 29925191 |
Jaundice cholestatic | 12.66 | 11.62 | 18 | 27111 | 4533 | 29920816 |
Headache | 12.65 | 11.62 | 105 | 27024 | 182201 | 29743148 |
Hepatic vein stenosis | 12.50 | 11.62 | 3 | 27126 | 16 | 29925333 |
Red blood cell schistocytes present | 12.47 | 11.62 | 6 | 27123 | 314 | 29925035 |
Immunosuppressant drug level increased | 12.21 | 11.62 | 18 | 27111 | 4684 | 29920665 |
Melanoderma | 12.15 | 11.62 | 5 | 27124 | 180 | 29925169 |
Suicidal ideation | 12.11 | 11.62 | 9 | 27120 | 36105 | 29889244 |
Drug intolerance | 11.99 | 11.62 | 14 | 27115 | 45277 | 29880072 |
Musculoskeletal stiffness | 11.95 | 11.62 | 9 | 27120 | 35872 | 29889477 |
Post transplant lymphoproliferative disorder | 11.93 | 11.62 | 19 | 27110 | 5287 | 29920062 |
Transplant rejection | 11.91 | 11.62 | 26 | 27103 | 9180 | 29916169 |
Lethargy | 11.83 | 11.62 | 11 | 27118 | 39508 | 29885841 |
Cystic fibrosis hepatic disease | 11.68 | 11.62 | 3 | 27126 | 22 | 29925327 |
Biliary tract disorder | 11.63 | 11.62 | 8 | 27121 | 827 | 29924522 |
Source | Code | Description |
---|---|---|
ATC | A05AA02 | ALIMENTARY TRACT AND METABOLISM BILE AND LIVER THERAPY BILE THERAPY Bile acids and derivatives |
FDA CS | M0002475 | Bile Acids and Salts |
FDA EPC | N0000175802 | Bile Acid |
MeSH PA | D002756 | Cholagogues and Choleretics |
MeSH PA | D005765 | Gastrointestinal Agents |
CHEBI has role | CHEBI:75771 | mus musculus metabolite |
CHEBI has role | CHEBI:77746 | h. sapiens metabolites |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Primary biliary cirrhosis | indication | 31712002 | DOID:12236 |
Calculus in biliary tract | indication | 266474003 | |
Cholelithiasis Prevention | indication |
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 4.92 | acidic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Bile acid receptor | Nuclear hormone receptor | AGONIST | CHEMBL | CHEMBL | |||||
Aldo-keto reductase family 1 member C2 | Enzyme | WOMBAT-PK | |||||||
G-protein coupled bile acid receptor 1 | GPCR | EC50 | 5.62 | CHEMBL | |||||
M1-family alanyl aminopeptidase | Unclassified | IC50 | 5.59 | CHEMBL |
ID | Source |
---|---|
4019318 | VUID |
N0000147507 | NUI |
D00734 | KEGG_DRUG |
4019318 | VANDF |
C0042105 | UMLSCUI |
CHEBI:9907 | CHEBI |
CHEMBL1551 | ChEMBL_ID |
D014580 | MESH_DESCRIPTOR_UI |
4920 | INN_ID |
DB01586 | DRUGBANK_ID |
724L30Y2QR | UNII |
31401 | PUBCHEM_CID |
7104 | IUPHAR_LIGAND_ID |
11065 | RXNORM |
31954 | MMSL |
5659 | MMSL |
d01005 | MMSL |
001212 | NDDF |
108669000 | SNOMEDCT_US |
41143004 | SNOMEDCT_US |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Actigall | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0023-6145 | CAPSULE | 300 mg | ORAL | NDA | 18 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0378-1730 | CAPSULE | 300 mg | ORAL | ANDA | 18 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0527-1326 | CAPSULE | 300 mg | ORAL | ANDA | 19 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0591-2998 | TABLET | 250 mg | ORAL | NDA AUTHORIZED GENERIC | 24 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0591-3005 | TABLET | 500 mg | ORAL | NDA AUTHORIZED GENERIC | 24 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0591-3159 | CAPSULE | 300 mg | ORAL | NDA authorized generic | 18 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0615-1374 | CAPSULE | 300 mg | ORAL | NDA | 17 sections |
Ursodiol 200 mg | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0722-7143 | CAPSULE | 200 mg | ORAL | ANDA | 19 sections |
Ursodiol 400 mg | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0722-7144 | CAPSULE | 400 mg | ORAL | ANDA | 19 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0904-6221 | CAPSULE | 300 mg | ORAL | ANDA | 12 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0904-6890 | TABLET, FILM COATED | 250 mg | ORAL | ANDA | 24 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 10135-543 | CAPSULE | 300 mg | ORAL | ANDA | 18 sections |
URSODIOL | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16590-349 | CAPSULE | 300 mg | ORAL | NDA | 17 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 24658-780 | CAPSULE | 300 mg | ORAL | ANDA | 12 sections |
Ursodiol | Human Prescription Drug Label | 1 | 42385-946 | CAPSULE | 300 mg | ORAL | ANDA | 17 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 42806-503 | CAPSULE | 300 mg | ORAL | ANDA | 12 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 49884-412 | TABLET, FILM COATED | 250 mg | ORAL | ANDA | 24 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 49884-413 | TABLET, FILM COATED | 500 mg | ORAL | ANDA | 24 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50268-796 | CAPSULE | 300 mg | ORAL | ANDA | 12 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50268-797 | CAPSULE | 300 mg | ORAL | ANDA | 17 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51079-383 | CAPSULE | 300 mg | ORAL | ANDA | 18 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51224-151 | CAPSULE | 300 mg | ORAL | ANDA | 19 sections |
BAMBOO SALT Eunganggo Jook Yeom Toothpaste | HUMAN OTC DRUG LABEL | 7 | 53208-459 | PASTE | 0.02 g | DENTAL | OTC monograph not final | 4 sections |
BAMBOO SALT Eunganggo Jook Yeom | HUMAN OTC DRUG LABEL | 7 | 53208-505 | PASTE | 0.02 g | DENTAL | OTC monograph not final | 8 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54868-5033 | CAPSULE | 300 mg | ORAL | NDA AUTHORIZED GENERIC | 17 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 55154-3355 | CAPSULE | 300 mg | ORAL | ANDA | 12 sections |
Urso 250 | HUMAN PRESCRIPTION DRUG LABEL | 1 | 58914-785 | TABLET, FILM COATED | 250 mg | ORAL | NDA | 25 sections |
Urso Forte | HUMAN PRESCRIPTION DRUG LABEL | 1 | 58914-790 | TABLET, FILM COATED | 500 mg | ORAL | NDA | 25 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 60429-662 | CAPSULE | 300 mg | ORAL | ANDA | 18 sections |
Ursodiol | HUMAN PRESCRIPTION DRUG LABEL | 1 | 60687-100 | CAPSULE | 300 mg | ORAL | ANDA | 19 sections |